TFS Gulf
  • All categories
    • inPractice
    • Entrepreneur Story
    • Finance Leaders
    • Videos
TheFinanceStory
No Result
View All Result
  • Login
  • Register
Book 1:1 session with industry experts!
  TFS Gulf
  • All categories
    • inPractice
    • Entrepreneur Story
    • Finance Leaders
    • Videos
The finance story
No Result
View All Result
  • Login
  • Register
Book 1:1 session with industry experts!
The Finance Story
No Result
View All Result

This Israeli scientist’s startup is producing industrial red blood cells to save lives, encourages founders to be patient

Dr. Ari Gargir decided to leverage his knowledge of biotechnology to create universal red blood cells through Red C Biotech Ltd. It aims to reduce blood shortages around the globe.

Preeti Mondal by Preeti Mondal
Published date: 26th September, 2022
Last edited date: 24th June, 2023
SHARE (672)
This Israeli scientist's startup is producing industrial red blood cells to save lives, encourages founders to be patient
Share on FacebookShare on Twitter
  • Meet Dr. Ari Gargir, CEO & Founder of Red C Biotech Ltd. – which is developing an industrial process for the production of red blood cells from stem cells.
  • He learned the value of blood when a blood transfusion helped him survive a fatal paragliding accident.
  • Despite nearly 120 million blood units being donated every year, there is a constant shortage.
  • The Biotechnology Market Size is expected to reach approx US$ 3,102.94 billion by 2030, according to a Growth Plus Report.

Back story: Foraying into the biotech industry

My journey into science started as a child in fact even before I got into school. I would gather fossils on walking trips and then go research them (yes, my friends laughed at me!).

It was a given that I am going to be a scientist.

Fast forward I did my university studies at Tel Aviv University, one of the largest research universities in Israel.

It was during my BSc studies in Biology, that I understood ‘Biology is not just about chasing butterflies with nets, it’s also about the industry, production, and providing medicine to society.’

So, I pursued further studies doing an MSc in Biotechnology and a Ph.D. in Microbiology.

In 2000, I started my career in the biotech industry.

Over the years, I worked with various companies of all sizes including startups. I did a lot of product development, served as an R&D leader, and delivered technologies and dozens of products through development programs, from conception to commercialization with over $250M in sales.

I also got first-hand exposure to the commercial side of things like how products have to go to the market, regulatory, product management and marketing, R&D legal issues, budgets, and grant raising.

As I worked in a lot of product development processes, there was an urge to lead the same… I was on a constant lookout to solve a big problem for humanity!

What next?

How the idea of RedC Biotech came about

In 1990, I went paragliding one of those days during my Bachelor’s. Unfortunately, I met with an accident and lost a lot of blood in the process… Blood transfusion saved my life.

Then a thought occurred to me, “I got off easy when I needed a blood transfusion to survive. But how could I help the ones who are unable to survive because of blood loss-related emergencies or diseases?”

At that time, I didn’t have a lot of knowledge of blood transfusion safety, or how red blood cell transfusion worked but I started learning more about it.

To my surprise, I learned that in spite of nearly 120 million blood units donated every year the blood donation practice is not sustainable because of several reasons; bad weather, unlucky circumstances such as pandemics, and so on.

In fact, every year millions of people die because of trauma, surgery, chronic illness, and cancer treatments.

After quite a bit of research, I got to know about a special technology through Technion – Israel Institute of Technology. It allows you to produce product cells from stem cells, at an industrial level, and similarly, red blood cells. 

We recognized the technology’s potential to meet the needs of the blood donation industry.

That’s how the idea of RedC Biotech came about.

In simple words, we’re producing red blood cells, which are identical to the red blood cells that are produced naturally in our body. We’re going to create red blood cells using patented technology in state-of-the-art Bioreactors. It will fit almost all blood types on earth since it’s pathogen-free and has a very precise shelf life.

People have been producing red blood cells from stem cells for almost two decades now, but it never left the lab because of its sky-high cost.

We are committed to breaking the cycle and producing in large volumes that would lead to an economy of scale.

The flourishing startup ecosystem in Israel also worked as a catalyst for my entrepreneurial motivation.

Funding and a long journey ahead

To get going with the research, I got our first round of investment from friends and family. We also raised money from a popular crowd investment platform in Israel called PipelBiz.

Very recently we won a $500,000 prize at the “Aviram Awards – Tech For Humanity”, an event and pitch competition in Dubai, hosted by The Aviram Family Foundation, and Forbes.

So far, we have raised about $1.4 million… but this is not enough. We will need a lot of investment.

Everything is divided into milestones for us. So at this point, we’re looking for investments that will help us develop the product and bring us toward preclinical testing.

(It will take about two to three more years before we could start our preclinical testing!)

The next step would be renting additional lab space.

Then comes the cost of materials.

The third chunk of the investment will be going into clinical trials, which also cost a lot. (More or less in about five years, we should be able to register our product with the regulatory groups and be ready for commercialization).

Commercializing our product will also require lots of money.

The idea is to have a structure of licensing for the technology so that production can take place in different regions around the world.

As we move forward and develop more and more technologies, more patents will be associated with industrial groups or medical pharmaceutical companies in different regions.

Every one of these companies or groups that will get licensed, will have to deal with the regulatory requirements and authorities in their countries. They will also need to establish local production sites.

In terms of competition, there is EryPharm, a Paris-based Biotechnology company producing red blood cells using a different strategy.

But the bottom line is we are all on a mission to end blood shortages around the world and save people, which is all that matters.

Closing…

The Biotechnology Market Size is expected to reach approx US$ 3,102.94 billion by 2030, according to a Growth Plus Report.

Before venturing into the pharmaceutical or medical space, make sure that you are in this to do good for humankind and bring positive change to the world.

You need to take human health and sustainability into consideration. 

Being patient is the key, especially when you’re developing a product in the life sciences domain.

And in this domain, it takes, sometime, years to reach the final stage of a product that meets all the requirements of the targeted market.

All of these are extremely important when you are thinking about starting up.

 

Preeti Mondal

Preeti Mondal

Recommended for you

Uniqus Consultech, founded by ex-Big 4 leaders, raises ₹171 Cr in Series C
AI in Finance

Ex-KPMG Partner startup Uniqus aims IPO in 3-5 Years. Now raised ₹171 Crores

23rd April, 2025 | 4 mins read
India’s 2024 IPO minted seven new billionaires
Business and Startups

India’s 2024 IPO minted seven new billionaires

7th January, 2025 | 5 mins read
Ex-KPMG Partner led Uniqus aims for $150 Million revenue
Business and Startups

Ex-KPMG Partner’s Firm targets $150M revenue in ESG & Accounting Consulting

5th December, 2024 | 6 mins read
How this CA secured $1.62M seed funding after pitching 100+ investors
Business and Startups

CA raised $1.62Mn…but it wasn’t easy! Here is how he approached VCs.

4th November, 2024 | 10 mins read
Building startup focussed professional services firm
Business and Startups

CA co-founded startup focussed professional services firm: 3k+ clients, 80+ team, revenue ₹7.5 Crores

23rd October, 2024 | 11 mins read
feb.ai, AI bookkeeping and tax
AI in Finance

3 CAs AI-powered bookkeeping & tax compliance platform raised ₹16.8 Crores

21st October, 2024 | 3 mins read
Next Post
This specially-abled CA defied all odds to become self-dependent. Don't pity the differently-abled, provide fair opportunities.

This specially-abled CA defied all odds to become self-dependent. Don't pity the differently-abled, provide fair opportunities.

Start conversation Cancel reply

Your email address will not be published. Required fields are marked *

1:1 career advice platform

  • Manager

    Investment Banking (Front Office) at HDFC Bank.

  • Finance Director

    at Procter & Gamble (P&G)

  • Strategic Program & Ops Manager

    Risk and Internal Audit at Accenture

  • Vice President

    at Alcazar Capital

  • Manager ACR

    Accounting, Compliance and Reporting at EY

  • Senior Accountant

    at BDO Canada LLP

  • Regional Financial Coordinator and Project Manager

    at TotalEnergies

  • Accounts Manager

    at Sterling Perfumes Industries LLC (Fakhruddin Holdings)

BOOK 1:1 CALL

1:1 career advice platform

  • Manager ACR

    Accounting, Compliance and Reporting at EY

  • Senior Accountant

    at BDO Canada LLP

  • Regional Financial Coordinator and Project Manager

    at TotalEnergies

  • Accounts Manager

    at Sterling Perfumes Industries LLC (Fakhruddin Holdings)

BOOK 1:1 CALL
The Finance Story

The Finance Story empowers finance professionals—CFOs, consultants, accountants, tax experts, and bankers—to navigate critical market shifts, industry disruptions, and emerging technologies & trends.

How? We spotlight key opportunities in India and globally, equipping finance professionals with the insights and strategies to drive business growth, optimize decision-making, and position their companies at the forefront

Quick Links

  • Finance
  • Partners
  • Privacy and Policy
  • Terms of use

Follow us

  • /TheFinanceStory
  • @TheFinanceStory
  • /TheFinanceStory
  • @thefinancestory_com
  • TheFinanceStory

© 2022. The Finance Story. All Rights Reserved.

No Result
View All Result
  • TFS Gulf
  • Entrepreneur Story
  • Finance Leaders
  • Videos
  • Login
  • Sign Up

Welcome Back!

Sign In with Google
OR

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Sign Up with Google
OR

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
We use cookies to personalize your experience. By continuing to visit this website you agree to our use of cookies.
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?
Book 1:1 call with industry expert